Stock page

Embecta Corp (EMBC)

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Quote snapshot

$3.635
Daily change: —
ExchangeNAS
Updated2026-05-09T04:23:16.964944Z

Price chart

Price history

Name
Revenue
Cost Of Goods Sold
Gross Profit
Gross Margin %
Research Development
Selling General Admin Expense
Depreciation Depletion Amortization
Other Operating Expense
Total Operating Expense
Operating Income
Operating Margin
Interest Income
Interest Expense
Other Income Expense
Other Income Minority Interest
Other Net Income Loss
Ebit
Ebitda
Ebitda Margin
Pretax Income
Tax Provision
Tax Rate
Net Income Continuing Operations
Net Income Discontinued Operations
Net Income
Net Income Including Noncontrolling Interests
Is Preferred Dividends
Shares Outstanding
Eps Basic
Eps Diluted
Net Margin

SEC filings

Latest 10-K filing table

Date Form Accession Link